KAI PHARMACEUTICALS
KAI Pharmaceuticals is a drug discovery and development company with multiple, novel clinical-stage programs in the areas of cardiovascular disease, kidney disease and pain. KAI lead product candidate, KAI-9803, is currently in a Phase 2b study (PROTECTION AMI) designed to assess the effect of KAI-9803 on reducing myocardial injury in heart attack patients. KAI second core program, KAI-4169 for the treatment of secondary hyperparathyroidism (SHPT) in kidney disease patients, is expected to enter human clinical trials in 2010. KAI also has an ongoing pain program, KAI-1678, which is currently in Phase 2a testing.
KAI PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2002-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.kaipharmaceuticals.com
Total Employee:
10001+
Status:
Active
Contact:
650-244-1100
Email Addresses:
[email protected]
Total Funding:
52 M USD
Technology used in webpage:
SPF Amazon Amazon Ohio Region NameBright
Similar Organizations
Cahaba Pharmaceuticals
Cahaba Pharmaceuticals develops novel therapeutics and supportive care products for cancer patients.
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Sight Pharma Inc.
Sight Pharma develops novel therapies for oncology and cardiovascular diseases in collaboration with universities.
Current Advisors List
Current Employees Featured
Founder
Investors List
Skyline Ventures
Skyline Ventures investment in Series B - KAI Pharmaceuticals
InterWest Partners
InterWest Partners investment in Series B - KAI Pharmaceuticals
Intersouth Partners
Intersouth Partners investment in Series B - KAI Pharmaceuticals
Aberdare Ventures
Aberdare Ventures investment in Series B - KAI Pharmaceuticals
Investor Growth Capital Limited
Investor Growth Capital Limited investment in Series B - KAI Pharmaceuticals
MDS Capital
MDS Capital investment in Series B - KAI Pharmaceuticals
Delphi Ventures
Delphi Ventures investment in Series B - KAI Pharmaceuticals
Intersouth Partners
Intersouth Partners investment in Series A - KAI Pharmaceuticals
Skyline Ventures
Skyline Ventures investment in Series A - KAI Pharmaceuticals
InterWest Partners
InterWest Partners investment in Series A - KAI Pharmaceuticals
Official Site Inspections
http://www.kaipharmaceuticals.com
- Host name: ec2-13-223-25-84.compute-1.amazonaws.com
- IP address: 13.223.25.84
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "KAI Pharmaceuticals"
KAI Pharmaceuticals 2025 Company Profile: Valuation, Investors ...
KAI Pharmaceuticals General Information Description. Developer of biopharmaceutical drugs. The company develops therapeutics targeting protein kinase C, a family of enzymes focusing …See details»
KAI pharmaceutical - 2025 Company Profile - Tracxn
KAI Pharmaceuticals, Inc. Announces Initiation of Phase 1b Study of KAI-4169 for the Treatment of Secondary Hyperparathyroidism (SHPT)BioSpace • Sep 27, 2010 • KAI pharmaceutical …See details»
KAI Pharmaceuticals - Overview, News & Similar companies
Who is KAI Pharmaceuticals. KAI Pharmaceuticals is a biology-based, product-driven, drug discovery and development company leveraging protein kinase C (PKC) signaling to gener ate …See details»
KAI Pharmaceuticals - 2025 Company Profile - Tracxn
Mar 7, 2025 KAI Pharmaceuticals - Drug discovery and development for treating secondary hyperparathyroidism. Acquired by Amgen. Raised a total funding of $63M over 3 rounds from …See details»
KAI Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...
Apr 1, 2024 Explore KAI Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 17 clinical trials, 6 news, and 1 literature, Disease Domain ...See details»
Kai Pharmaceuticals, Inc - VentureRadar
Sunesis has built an experienced drug development organization committed to improving the lives of people with cancer. AcelRx Pharmaceuticals, Inc. USA Publicly Traded AcelRx …See details»
KAI Pharmaceuticals - VentureRadar
Find out more about KAI Pharmaceuticals, Biotechnology and Healthcare. All; Ranked; Organisation Names; Login Free Sign-up , . KAI is a clinical-stage, biopharmaceutical …See details»
Organization | KAI Pharmaceuticals
KAI Pharmaceuticals Report issue. Contributed to NME For profit Phase 1 Phase 2. Founded: South San Francisco CA United States ... Organization Overview. First Clinical Trial. 2004 …See details»
KAI Pharmaceuticals, Inc.:Company Profile & Technical Research ...
KAI Pharmaceuticals, Inc. is a company that provides Kidney disease, Medicine, Pharmacy and Therapeutics and more. KAI Pharmaceuticals, Inc. is headquartered in United States …See details»
KAI Pharmaceuticals - Funding, Financials, Valuation & Investors
KAI Pharmaceuticals discovers and develops novel therapeutics for cardiovascular diseases, kidney diseases and pain. Search Crunchbase. Start Free Trial . Chrome Extension. ... How …See details»
Kai Pharmaceuticals Inc - Company Profile and News
KAI Pharmaceuticals, Inc. researches, develops, and manufactures human therapeutics. The Company offers drugs for the treatment of chronic kidney disease and bone disorder in patients.See details»
Kai Pharmaceuticals, Inc - VentureRadar
Similar Companies: Collegium Pharma USA Private Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its …See details»
Kai Pharmaceuticals, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Kai Pharmaceuticals, Inc. of South San Francisco, CA. Get the latest business insights from Dun …See details»
KAI Pharmaceuticals - Ownership and Business Overview - Mergr
Apr 10, 2012 KAI Pharmaceuticals is a life science company based in South San Francisco. KAI's lead product candidate KAI-4169 is a novel agent being studied initially for the treatment …See details»
Nextsource | Company Profile | KAI Pharmaceuticals
Explore the company profile of KAI Pharmaceuticals (kaipharmaceuticals.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
KAI PHARMACEUTICALS Revenue, Growth & Competitor Profile
Kai Pharmaceuticals's Annual Report & Profile shows critical firmographic facts: What is the company's size? (Annual sales and employees) What industry is the company in? Recession …See details»
KAI Pharmaceuticals - VentureRadar
KAI Pharmaceuticals Follow Following " KAI is a clinical-stage, biopharmaceutical company whose lead peptide product candidate, KAI-4169, is in development for the treatment of …See details»
KAI Pharmaceuticals - Products, Competitors, Financials, …
KAI Pharmaceuticals is a privately held, venture-backed drug discovery and development company with preclinical and clinical programs in acute cardiovascular and other diseases …See details»
KAI Pharmaceuticals - Contacts, Employees, Board Members
Organization. KAI Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News ... KAI Pharmaceuticals has 2 current employee profiles, …See details»